The effect of platelet-derived microparticles in stored apheresis platelet concentrates on polymorphonuclear leucocyte respiratory burst

Vox Sanguinis

Volumn 106, Issue 3, 2014, Pages 234-241

  Xie, R F ^a   Hu, P ^b   Li, W ^b   Ren, Y N ^a   Yang, J ^a   Yang, Y M ^a   Wang, Z Y ^a   Fan, H H ^a  

^a Shanghai Blood Center   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

Platelet concentrates; Platelet transfusion; Platelet derived microparticles; Soluble CD40L; TRALI

Indexed keywords

CD40 LIGAND; CD40 LIGAND MONOCLONAL ANTIBODY; HYDROGEN PEROXIDE; LEUCINE; METHIONINE; PHENYLALANINE; THROMBOCYTE CONCENTRATE;

APHERESIS; ARTICLE; CELL ISOLATION; CENTRIFUGATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FILTRATION; FLOW CYTOMETRY; HUMAN; NEUTROPHIL; PLATELET MICROPARTICLE; PRIORITY JOURNAL; RESPIRATORY BURST; THROMBOCYTE FREE PLASMA; THROMBOCYTE PRESERVATION; TRANSFUSION RELATED ACUTE LUNG INJURY; WESTERN BLOTTING;

PLATELET CONCENTRATES; PLATELET TRANSFUSION; PLATELET-DERIVED MICROPARTICLES; SOLUBLE CD40L; TRALI;

ACUTE LUNG INJURY; BLOOD PLATELETS; BLOOD PRESERVATION; BLOOD TRANSFUSION; CD40 LIGAND; CELL AGING; CELL-DERIVED MICROPARTICLES; FLOW CYTOMETRY; HUMANS; INFLAMMATION MEDIATORS; NEUTROPHILS; PLATELET TRANSFUSION; PLATELETPHERESIS; RESPIRATORY BURST;

EID: 84896548648     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12092     Document Type: Article

References (39)

1. Elzey BD, Sprague DL, Ratliff TL: The emerging role of platelets in adaptive immunity. Cell Immunol 2005; 238:1-9
2. Keuren JF, Magdeleyns EJ, Govers-Riemslag JW, et al.: Effects of storage-induced platelet microparticles on the initiation and propagation phase of blood coagulation. Br J Haematol 2006; 134:307-313
3. Berckmans RJ, Nieuwland R, Böing AN, et al.: Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85:639-646
4. McVey M, Tabuchi A, Kuebler WM: Microparticles and acute lung injury. Am J Physiol Lung Cell Mol Physiol 2012; 303:L364-L381
5. Sun X, Singleton PA, Letsiou E, et al.: Sphingosine-1-phosphate receptor 3 is a novel biomarker in acute lung injury. Am J Respir Cell Mol Biol 2012; 47:628-636
6. Buesing KL, Densmore JC, Kaul S, et al.: Endothelial microparticles induce inflammation in acute lung injury. J Surg Res 2011 Mar; 166:32-39
7. Shantsila E, Kamphuisen PW, Lip GY: Circulating microparticles in cardiovascular disease: implications for atherogenesis and atherothrombosis. J Thromb Haemost 2010; 8:2358-2368
8. Boilard E, Nigrovic PA, Larabee K, et al.: Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 2010; 327:580-583
9. Koga H, Sugiyama S, Kugiyama K, et al.: Elevated levels of remnant lipoproteins are associated with plasma platelet microparticles in patients with type-2 diabetes mellitus without obstructive coronary artery disease. Eur Heart J 2006; 27:817-823
10. Merten M, Pakala R, Thiagarajan P, et al.: Platelet Microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 1999; 99:2577-2582
11. Sadallah S, Eken C, Martin PJ, et al.: Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol 2011; 186:6543-6552
12. Mause SF, Hundelshausen PV, Zernecke A, et al.: Platelet Microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005; 25:1512-1518
13. Blumberg N, Spinelli SL, Francis CW, et al.: The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res 2009; 45:251-260
14. Sahler J, Spinelli S, Phipps R, et al.: CD40 ligand (CD154) involvement in platelet transfusion reactions. Transfus Clin Biol 2012; 19:98-103
15. Andre P, Nannizzi-Alaimo L, Prasad SK, et al.: Platelet derived CD40L: the switch-hitting player of cardiovascular disease. Circulation 2002; 106:896-899
16. Fan Y, Ge Y, Zhu H, et al.: Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L. Tissue Antigens 2004; 64:257-263
17. Blumberg N, Gettings KF, Turner C, et al.: An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion 2006; 46:1813-1821
18. Khan SY, Kelher MR, Heal JM, et al.: Soluble CD40 ligand accumulates in stored blood components, primes -neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood 2006; 108:2455-2462
19. Ahn ER, Lander G, Jy W, et al.: Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic risk. Thromb Res 2004; 114:143-148
20. Varo N, Nuzzo R, Natal C, et al.: Influence of pre-analytical and analytical factors on soluble CD40L measurement. Clin Sci 2006; 111:341-347
21. Sprague DL, Elzey BD, Crist SA: Platelet-mediated modulation of adaptive immunity- unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008; 111:5028-5036
22. Jy W, Horstman LL, Jimenez JJ, et al.: Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2:1842-1851
23. Robert S, Poncelet P, Lacroix R, et al.: Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies? J Thromb Haemost 2008; 7:190-197
24. Bitzinger DI, Schlachetzki F, Lindner R, et al.: Flow-cytometric measurement of respiratory burst in rat polymorphonuclear granulocytes: comparison of four cell preparation procedures, and concentration-response evaluation of soluble stimulants. Cytometry A 2008; 73:643-650
25. Kono1 M, Saigo K, Takagi Y, et al.: Morphological and flow-cytometric analysis of haemin-induced human neutrophil activation-implications for transfusion-related acute lung injury. Blood Transfus 2013; 11:53-60
26. Ambruso DR, Thurman G, Tran K, et al.: Generation of neutrophil priming activity by cell-containing blood components treated with pathogen reduction technology and stored in platelet additive solution. Transfusion 2011; 51:1220-1227
27. Warren BA, Vales O: The release of vesicles from platelets following adhesion to vessel walls in vitro. Br J Exp Patho 1972; 53:206-15
28. Bode AP, Orton SM, Frye MJ, et al.: Vesiculation of platelets during in vitro aging. Blood 1991; 77:887-895
29. George JN, Pickett EB, Heinz R: Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986; 68:307-309
30. Sugawara A, Nollet KE, Yajima K, et al.: Preventing platelet-derived microparticle formation-and possible side effects-with prestorage leukofiltration of whole blood. Arch Pathol Lab Med 2010; 134:771-775
31. Silliman CC, Khan SY, Bradley Ball J, et al.: Mirasol pathogen reduction technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components. Vox Sang 2010; 98:525-530
32. Tung JP, Fraser JF, Nataatmadja M, et al.: Dissimilar respiratory and hemodynamic responses in TRALI induced by stored red cells and whole blood platelets [52nd Annual Meeting of the American Society of Hematology]. Blood 2010; 116:484, Ab#1112. 13
33. Tung JP, Fung YL, Nataatmadja M, et al.: A novel in vivo ovine model of transfusion-related acute lung injury (TRALI). Vox Sang 2011; 100:219-230
34. Cardo LJ, Wilder D, Salata J: Neutrophil priming, caused by cell membranes and microvesicles in packed red blood cell units, is abrogated by leukocyte depletion at collection. Transfus Apheres Sci 2008; 38:117-125
35. Fung YL, Silliman CC: The role of neutrophils in the pathogenesis of transfusion-related acute lung injury (TRALI). Transfus Med Rev 2009; 23:266-283
36. Bercovitz RS, Kelher MR, Khan SY, et al.: The pro-inflammatory effects of platelet contamination in plasma and mitigation strategies for avoidance. Vox Sang 2012; 102:345-353
37. Pietravalle F, Lecoanet-Henchoz S, Blasey H, et al.: Human native soluble CD40L is a biologically active trimer, processed inside microsomes. J Biol Chem 1996; 271:5965
38. Reinboldt S, Wenzel F, Rauch BH, et al.: Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets. Platelets 2009; 20:441-444
39. Tuinman PR, Gerards MC, Jongsma G, et al.: Lack of evidence of CD40 ligand involvement in transfusion-related acute lung injury. Clin Exp Immunol 2011; 165:278-284